ONTX - Onconova Therapeutics Inc. • BioPharmCatalyst NewsSee all news. 18 March 2020 Onconova Therapeutics to Provide Corporate Update and Full Year 2019 Financial Results. NEWTOWN, Pa., March 18, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a focus ONTX - Another offering : pennystocks It's a 2020 play. Honestly, this seems like a really good price. LOTs of positives on this stock I can't cover right now but can easily be found. I just wish they'de let it run on good news. However, they're funded through Q4 2020 now and it was a direct offering, so it's not that bad. ONTX after offering : RobinHoodPennyStocks
10 Mar 2020 On Friday, shares of Onconova Therapeutics, Inc. (NASDAQ:ONTX) marked $0.46 per share versus a previous…
22 Mar 2020 $ONTX Stick to stocks you know about that you have researched. I have said this before in the current market sentiment don't be long on stocks Toggle Summary Jan 03, 2020, Onconova Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The- The shares are expected to begin trading on The NASDAQ Global Market on July 25, 2013 under the ticker symbol "ONTX." The offering is expected to close on 3 Jan 2020 (NASDAQ: ONTX) (“Onconova” or the “Company”), a Phase 3-stage The shares of common stock described above were offered and sold 25 Nov 2019 Offering led by healthcare dedicated funds, including Knight Therapeutics Inc. ( NASDAQ: ONTX) (“Onconova”), a Phase 3-stage biopharmaceutical with accompanying common stock warrants, at a public offering price of ONTX | Complete Onconova Therapeutics Inc. stock news by MarketWatch. Onconova Therapeutics prices $2.5 mln stock offering at $2.10 a share. Apr. 21 View ontx business summary and other industry information. Emma Court. Onconova Therapeutics stock drops 12% after pricing stock offering. 9:55 a.m. April
Onconova Therapeutics, Inc. Announces $3.4 Million ...
In terms of volatility of its share price, ONTX is more volatile than 98.71% of stocks we're observing. Stocks with similar financial metrics, market capitalization , and Webull offers Onconova ONTX historical stock prices, in-depth market analysis, NASDAQ:ONTX real-time stock quote data, in-depth charts, and a fully built Find out if ONTX is the best investment for you. Start a 14-day free trial to Morningstar Premium to unlock our take on ONTX. 10 Mar 2020 This is a good sign as it is always nice to have a liquid stock. ONTX is part of the Drugs industry. There are 640 other stocks in this industry, ONTX View the latest ONTX stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ONCONOVA THERAPEUTICS, INC.. Real time Onconova Therapeutics (ONTX) stock price quote, stock graph, news & analysis.
Market Cap 48.6M. Shares Outstanding 167.3M symbol, last, chg, %chg Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
analysis and events related to ONCONOVA THERAPEUTICS INC (ONTX). of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market.
Stock analysis for Onconova Therapeutics Inc (ONTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
31 Dec 2019 The shares of common stock described above are being offered and sold by the Company pursuant to a “shelf” registration statement on Form Find the latest Onconova Therapeutics, Inc. (ONTX) stock quote, history, news and other vital information to help you with your stock trading and investing. 22 Mar 2020 $ONTX Stick to stocks you know about that you have researched. I have said this before in the current market sentiment don't be long on stocks
Dec 18, 2019 · Company does not intend to raise additional capital for ninety days following the closing of the offering; Onconova Therapeutics, Inc. (ONTX) (“Onconova” or the “Company”), a institutional investors for the issuance and sale in a registered direct offering of 13,878,864 shares of its common stock and warrants to Breaking News: ONTX latest news. - The Fly Onconova Therapeutics announced that it has entered into definitive agreements with two healthcare-focused institutional investors for the issuance and sale in a registered direct offering of 27.66M shares of its common stock at a purchase price of 36.15c per share, for aggregate gross proceeds of approximately $10M in a registered direct offering priced at-the-market under Nasdaq rules. Current Report Filing (8-k)